Skip to main content
OpenTrials

Clinical trial condition

Haemophilia B With Inhibitors

Explore clinical trials studying Haemophilia B With Inhibitors. Study availability and eligibility vary by location and protocol.

25 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Haemophilia B With Inhibitors trial results

Completed

High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors

NCT00571584

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Le Kremlin-Bicêtre, France
  • Novo Nordisk Investigational Site Lille, France
  • Novo Nordisk Investigational Site Lyon, France
  • Novo Nordisk Investigational Site Paris, France
View all 18 locations
View Trial Details
Completed

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

NCT00108758

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Berkeley, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Chicago, Illinois, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
View all 37 locations
View Trial Details
Completed

Trial of NovoSeven® in Haemophilia - Joint Bleeds

NCT00108797

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Little Rock, Arkansas, United States
  • Novo Nordisk Investigational Site Berkeley, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 20 locations
View Trial Details
Completed

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

NCT00703911

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Brussels, Belgium
  • Novo Nordisk Investigational Site Prague, Czechia
View all 16 locations
View Trial Details
Completed

PROPACT: Retrospective Prophylaxis Patient Case Collection

NCT00882778

Conditions
Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Locations
  • Novo Nordisk Investigational Site Princeton, New Jersey, United States
  • Novo Nordisk Investigational Site Prov. de Buenos Aires, Argentina
  • Novo Nordisk Investigational Site Mississauga, Canada
  • Novo Nordisk Investigational Site Zagreb, Croatia
View all 14 locations
View Trial Details

Related conditions